NYSEMKT: IBO
Impact Biomedical Inc Stock Ownership - Who owns Impact Biomedical?

Insider buying vs selling

Have Impact Biomedical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dss Inc10% Owner2026-09-24156$7.06
$1.10kSell
Dss Inc10% Owner2026-09-2327$6.95
$187.65Sell
Dss Inc10% Owner2026-09-22723$0.55
$397.65Sell
Todd D. MacKoChief Financial Officer2026-03-2743,400$0.56
$24.35kSell
Todd D. MacKoChief Financial Officer2026-03-251,600$0.60
$961.60Sell
Jason GradyDirector2026-03-2350,000$0.65
$32.50kSell

1 of 1

IBO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IBO insiders and whales buy or sell their stock.

IBO Shareholders

What type of owners hold Impact Biomedical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dss Inc2.41%2,601,400$14.80MInsider
Jason Grady0.23%250,182$1.42MInsider
Todd D. MacKo0.14%155,122$882.64kInsider
Frank D. Heuszel0.09%97,344$553.89kInsider
Geode Capital Management LLC0.00%1,185$6.74kInstitution
Geodec0.00%1,185$6.74kInstitution
Vangrd0.00%809$4.60kInstitution
Vanguard Capital Management LLC0.00%808$4.60kInstitution
Stastr0.00%608$3.46kInstitution
State Street Corp0.00%607$3.45kInstitution

1 of 3

IBO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IBO0.00%2.88%Net SellingNet Selling
CRMD0.06%9.82%Net SellingNet Selling
STTK0.08%15.04%Net BuyingNet Selling
AURA0.09%4.39%Net Selling
BLSM0.00%56.05%Net BuyingNet Buying

Impact Biomedical Stock Ownership FAQ

Who owns Impact Biomedical?

Impact Biomedical (NYSEMKT: IBO) is owned by 0.00% institutional shareholders, 2.88% Impact Biomedical insiders, and 97.12% retail investors. Dss Inc is the largest individual Impact Biomedical shareholder, owning 2.60M shares representing 2.41% of the company. Dss Inc's Impact Biomedical shares are currently valued at $14.80M.

If you're new to stock investing, here's how to buy Impact Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.